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Abstract
Complication of retinopathy in type 2 DM is caused of lower level of NO.  Nitric oxide level is synthesized 
from L-arginin in reaction that catalyze Nitric oxide synthase (NOS) 3.  The  T-786C mutation in NOS 3 gene 
decreases the expression of nitric oxide synthase (NOS) 3 so decreases NO synthesis. To investigate the 
association between T-786C polymorphism in NOS 3 gene with NO level of diabetic retinopathy patients. This 
study was a case control study, consist of 40 patient of type 2 diabetic with DR (case group) and 40 patient of 
type 2 diabetic without DR (control group) of Javanese ethnic. The genotyping of T-786C polymorphism was 
performed by PCR-RLFP. Level of NO was measured by spectrophotometry. Chi square test and odd ratio 
were used to analyze the association of the T-786C polymorphism in NOS 3 gene with DR. Differences of 
NO level between TT and TC genotypes were analyzed using independent t test. The distribution of T-786C 
polymorphism in NOS 3 gene of DR subjects showed that frequency of TT genotype was 22.5% and TC genotype 
was 77.5%. Non DR subjects showed the frequency of TT genotype was 50% and TC genotype was 50%, (p= 
0.011).  Frequency of T allele in DR group was 61.25% and C allele was 38.75%, and frequency of T allele in non 
DR group was 75% and C allele was 25%, (p= 0.62).  Odd ratio of TC genotype was 3.444(CI; 95% : 0.964-3.735) 
and C allele was 1.898 (CI; 95% : 1.310-9.058).  The NO level of TC genotype was 1.43+0.126 and TT genotype 
was 11.27+5.87 (p=0.000).  Level of NO  between RD and non RD showed not different significantly (p=0.160) 
for retinopathy. The T-786C polymorphism of NOS 3 gene is risk factor for retinopathy in type 2 Diabetes 
Mellitus.  Individual with TC genotype of NOS 3 gene has lower level of NO than TT genotype.    
Keywords : Diabetic Retinopathy, Polymorphism, Nitric Oxide, Nitric Oxide Synthase.   
Introduction
Diabetes Mellitus (DM) is a metabolic 
disease characterized by hyperglycemia. 
It is caused by defect on insulin secretion, 
insulin activity, or both (Gustaviani, 2006). 
Based on WHO database, the number of 
DM patients in the world has reached 171 
million people (2.8% of world population). 
In 2007, the prevalence of DM in Indonesia 
was approximately 5.7% (Depkes RI, 2008). 
In Yogyakarta, the DM patients has reached 
approximately 150/10.000 citizens, therefore 
its prevalence is 1.6% (Depkes RI, 2008). 
The complications of DM is retinopathy, 
nephropathy, and peripheral neuropathy. 
Diabetic Retinopathy (DR) is a microvascular 
complication which causes blindness 
(Gustaviani, 2006). The prevalence of DR in 
the world is 40%, in Indonesia is about 40-
50% (Masduki et al., 2008). In Yogyakarta, the 
prevalence of DR in rural area is 8.7%, while 
in suburban is 7.7% (Gustaviani, 2006).
Retinal defect caused by hyperglycemia 
involves some pathways, such as non-
enzymatic glycation, protein kinase C 
activation, increase of oxidative stress, polyol 
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pathway, and decrease of NO. Chronic 
hyperglycemia increases free radicals, 
especially reactive oxygen species, in all of 
tissues causes oxidative stress. Oxidative 
stress cause change of the structural and 
functional retinal microvascular (Miyamoto  et 
al., 2000) that is thickening of basal membrane 
and microvascular,  loses the capillary form. 
Furthermore, structural changes may alter 
the function of pericyte cells and endothelial 
cells, such as decrease of blood stream, loss of 
intercellular junction, and increase of vessel 
permeability. The contractility of pericytes 
of retinal capillary is inhibited by high 
concentration of glucose. It is the early step 
of DR pathogenesis (Gillies and Su, 1993). 
Several studies reported that several 
genes influence the development of DR. One of 
those gene is endothelial nitric oxide synthase 
(eNOS) or NOS 3 gene. NOS 3 gene is located 
in chromosome 7 (7q36). This gene encodes 
NOS 3 which catalyzes the formation of NO 
by the conversion of L-arginin to L-citrullin 
(Mayer and Hemes, 1997). Ezzidi et al., 2008 
investigated T-786C polymorphism in NOS 
3 gene that located in -786 bp upstream from 
NOS 3 gene. This polymorphism causes the 
conversion of timine to cytocine which leads to 
the decrease of NO synthesis. Low level of NO 
causes vasoconstriction, platelet aggregation, 
and angiogenesis. 
The objective of this study was to give 
description about the relationship of T-786C 
polymorphism in NOS 3 gene as risk factor 
for DR in type 2 DM patients of Dr. Sardjito 
Hospital, Yogyakarta and level of NO.  
Materials and Methods
This research was a case-control study 
with 40 subjects of type 2 DM patients with 
DR as the case group and 40 subjects of type 2 
DM patients without DR as the control group. 
The patients were the outpatients of Dr. 
Sardjito Hospital and they are all Javanese. 
The inclusion criteria of the research subject 
were aged 35-65 years, have been diagnosed 
as type 2 DM patient minimally for 5 years, 
body mass index ≤ 25 kg/m (WHO, 2006; 
Supariasa et al., 2001), did not suffer from 
dyslipidemia, systolic blood pressure < 180 
mmHg and diastolic blood pressure < 120 
mmHg (JNC 7, 2003), did not have any eye 
disease. Informed consent was obtained from 
each subject.
Diagnosis of DM was established when 
the level of fasting plasma glucose ≥ 120 mg/
dL and 2-h plasma oral glucose tolerant ≥ 
200 mg/dL (American Diabetes Association, 
2010). The criterion of retinopathy was 
based on the photofundus examination that 
showed one of retinopathy symptoms, such 
as microaneurism, hemorrhage, exudates, 
or/and neovascularization.  
The data obtained from the subjects 
were age, sex, course of DM, BMI, and blood 
pressure. NO level was measured using 
spectrophotometry with Griess reaction. The 
measurements of GDP and G2PP levels used 
GOD-PAP, while triglyceride, HDL, and LDL 
HDL, and LDL levels were measured using 
CHOD-PAP levels were measured using 
CHOD- PAP. The data was analyzed with 
independent t test. 
Genotyping of NOS 3 gene polymorphism
The T-786C polymorphism in NOS 
3 gene was determined with PCR-RLFP 
method. The PCR conditions were 94oC for 
5s; followed by 40 cycles of 94oC for 1 min, 
61oC for 1 min, 72oC for 1 min; and final 
extension at 72oC for 5 min. The primers 
used in this study were 5’-TGG AGA GTG 
CTG GTG TAC CCC A-3’ (forward primer) 
and 5’-GCC TCC ACC CCC ACC CTG TC-
3’ (reverse primer). From this amplification, 
PCR product of 180 bp was expected (Ezzidi 
et al., 2008).
The enzyme for restriction was MspI 
restriction enzyme (New England Biolabs). 
The result of digestion for 16 h was then 
electrophorized with 2% agarose gel and 
visualized with ethidium bromide under 
UV light. Two fragments; 140 and 40 bp; 
represented TT genotype. Four fragments; 
140, 90, 50, and 40 bp; represented TC 
genotype, while three fragments; 90, 50, 
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Table 1. Characteristics of the studied population    
Variables Diabetic Retinopathy Non DR p (95%CI)
Number of subjects
Sex : male (%)
         female (%)
40
13 (32.5%) 
27 (67.5%)
40
12 (30%)
28 (70%)
-
Age (year)# 55,58+7,91 56,03+8,26 0,797 54,01-57,59
BMI (kg/m2)# 21,93+2,83 23,37+1,84 0,018* 4,69-4,81
Systolic blood pressure(mmHg)# 124,25+11,07 123,00+12,03 0,648 2,08-2,9
Diastolic blood pressure(mmHg)# 79,50+9,04 80,25+8,00 0,809 1,01-1,89
GDP (mg/dL)# 167,18 +69,83 142,26+66,23 0,062 11,58-12,94
Glucose 2 PP (mg/dL) 232,41+76.13 206.29+91.80 0,362 0,04-0,08
Triglyceride (mg/dL)# 122,91+26,89 137,02+33,12 0,862 13,07-13,89
Total cholesterol (mg/dL) 172.81+47,02 171,02+26,65 0,302 10,47-11,88
HDL (mg/dL) 75,34+17,01 72,19+ 12,95 0,252 10,90-11,98
LDL (mg/dL)# 101,95+23,80 101,41+19,30 0,130 92,88-91,81
Note : # calculated with Mann Whitney test 
Figure 1. Genotype of TC and TT at -786 position NOS 3 gene
and 40 bp; represented CC genotype. The 
difference of genotype and allele frequencies 
between case and control groups were 
analyzed by chi-square test. The Odd Ratio 
test was used to analyze the extent to which 
various genotypes and alleles of T-786C 
polymorphism in NOS 3 gene was associated 
with DR.
Results
A total of 80 Javanese that consisted of 
40 type 2 DM patients with DR and 40 type 
2 DM patients without DR, was enrolled in 
this study. The characteristics of the studied 
population were shown in Table 1. BMI of DR 
patients and non DR patients was significantly 
different, but the average value of both groups 
was in normal range (Table 1).   
The result of genotype analysis of 
T-786C polymorphism in NOS 3 gene using 
PCR-RFLP is shown in Figure 1.
The genotype and allele distribution 
of T-786C polymorphism in NOS 3 gene is 
shown in Table 2 while the Hardy-Weinberg 
equilibrium is shown in (Table 3).
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Table 2.  The genotype frequency of T-786C 
polymorphism in NOS 3 gene
Type 2 
DM
Genotype p 
(CI=95%)TT TC CC
DR 9 (22.5%) 31 (77.5%) 0 (0%)
0.011
non DR  20 (50%) 20 (50%) 0 (0%)
  
Pearson Chi-square analysis showed 
there was significantly different of genotype 
-786 NOS 3 gene in DR and non DR patients 
(p = 0.011). 
Table 3.  The genotype frequency of T-786C 
polymorphism in NOS 3 gene between the observed and 
the expected values (Hardy-Weinberg equilibrium)
Genotype 
Result
p 
(95%CI)Observed 
value
Expected 
value
TT 
TC
CC
29
51
0
37
35
8
0.05
 
With Hardy-Weinberg equilibrium, TT 
genotype was 37, TC genotype was 35, and 
CC genotype was 8. With Pearson chi-square 
analysis showed a significant difference between 
the observed value and the expected (Hardy-
Weinberg equilibrium) (p= 0.05) (Table 3).
Table 4. The odds ratio of T-786C genotype and allele 
in NOS 3 gene
Variables
Type 2 DM
OR 95% CIDR 
(n=40)
non DR 
(n=40)
Genotype TC 
TT
31
9
20
20
3.444 1.310-9.058
Allele C 
T
31
49
20
60
1.898 0.964-3.735
The TC genotype and C allele were risk 
factor for DR in type 2 DM patients with OR 
3.444 and 1.898 respectively (Table 4). The 
probability to have complication was P = 
OR/(1+OR).  The probability of individuals 
with TC genotype to suffer from DR was 
77.49%, while the probability of C allele 
carriers to suffer from DR was 65.49%.
The influence of TT and TC genotypes 
of NOS 3 gene toward NO level in type 2 DM 
was shown in Table 5.
Table 5. The average of NO level between genotypes 
of T-786C polymorphism in NOS 3 gene in type 2 DM 
patients
type 2 
DM
NO level (pg/mL)
p
(CI=95%)TT genotype 
(n=60)
TC genotype 
(n=20)
DR and 
non DR 7.99+5.25 1.23+1.71 0,000*
 
The average of NO level in individuals 
with TT genotype was higher than that in 
individuals with TC genotype (7.99+5.25 
mg/dL vs 1.23+1.71 mg/dL) and this was 
statistically different (p=0.000).
The average of NO level between 
genotypes in DR and without DR type 2 DM 
was shown in Table 6.
Table 6. The average type 2 DM of NO level between 
genotypes in patients with DR and without DR
type 2 DM
NO blood level      (pg/mL) p
(CI=95%)TT genotype TC genotype 
DR 11.27 +5.87 1.43+2.13 0.000*
non DR 6.52+4.32 0.93+0.65 0.000*
In type 2 DM patients with DR, the 
average of NO level in individuals with TC 
genotype was lower than that in individuals 
with TT genotype, and this was statistically 
different (p=0.000). Similar condition was 
also met in type 2 DM patients without DR.
Discussion
Genotyping of T-786C polymorphism 
in NOS 3 gene in this research only found 
2 genotypes, TT and TC genotypes. This 
result was different with the result of  Ezzidi 
et al.(2008) and Awata et al.(2004) That 
found TT, TC, and CC genotypes. Liew et 
al.(2009) stated that development of DR was 
influenced by environmental and genetic 
factors in population study.
TC genotype and C allele in -786 NOS 3 
gene was significant different between type 2 
DM with DR and non DR. Individuals with 
TC genotype had 3.4 time increased risk 
for DR than individuals with TT genotype, 
while C allele carriers had 1.9 increased 
risk for DR. However, Ezzidi et al. (2008) 
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reported that there was no statistically 
significant different of T-786C polymorphism 
between DR patients and non DR patients 
in Tunisia (p=0.069).  Awata et al.(2004) also 
reported a similar results as Ezzidi et al.(2008) 
(p=0.367). The different of ethnic was one of 
the factors which influence the different in 
genotype frequency. Moreover, the different 
of environment  in each population  influence 
the development of DR (Liew et al., 2009).
The T-786C polymorphism is located 
in basal region of NOS 3 gene promoter, 
that is an active functional element. Ezzidi 
et al. (2008) reported that allele differences 
in T-786C polymorphism influence the 
function and binding activity of nuclear 
factor that changes transcription level of NOS 
3 gene. Decreased expression of NOS 3 gene 
identified in retinal endothelial cells occur in 
individuals with CC genotype (Awata et al., 
2004). Shear stress stimulates expression of 
NOS 3 synthesis in endothelial cells, especially 
the expression of NOS 3 in basal membrane 
of individuals with TT genotype (Cattaruza et 
al., 2004).  On the other hand, the expression 
of NOS 3 in individuals with CC genotype 
did not influence by shear stress. There was 
variance in the promoter region to interact 
with transcription factor which stimulated 
by shear stress. Besides that, the binding 
between variant in promoter region and 
transcription factor inhibit protein binding 
to DNA. In other word, the replication of 
A1 protein interacted with promoter with 
C allele. A1 protein as repressor protein 
(Miyamoto et al.,2000).
The frequency of TT and TC genotypes 
of NOS 3 gene between type 2 DM patients 
with DR and without DR was statistically 
different (p=0,011). In this study, the Hardy-
weinberg equlibrium was not fulfilled. 
Perhaps it was caused by the small number 
of the studied population, which was not 
yet enough to fulfilled the equilibrium. 
Moreover, all of the subjects were type 2 DM 
patients in Dr. Sardjito Hospital, who were 
possibly did not represented the population 
in the community. 
This study reported that lower level of 
NO occurred in individuals with TC genotype 
than those with TT genotype. Awata et al. 
(2004) reported the lower of NOS 3 activity 
in blood of type 2 DM patients with DR than 
type 2 DM patients without DR. The lower of 
NOS 3 activity cause the lower level of NO 
in type 2 DM patients with DR compared to 
type 2 DM patients without DR.
A low NO level induce the proliferation 
of smooth muscle of retinal microvascular 
(Singh et al., 2009). That condition stimulate 
oxidative stress in retina that lead to change 
in the structural and functional of retina.  Free 
radical from ROS induced DNA modifications. 
Reactive Oxygen Species (ROS) increased 
the vascular permeability and occlusions, 
decreased of blood flow, disturbed the retinal 
microvascular barrier, which eventually 
resulted in retinal neovascularization in DR 
patient (Cattaruza et al., 2004).
In summary, the T-786C polymorphism 
in NOS 3 gene was a risk factor for DR in 
type 2 DM patient. Individuals with TC 
genotype had lower NO level than TT 
homozygous individuals. Further study 
on T-786C polymorphism in NOS 3 gene 
in different ethnics and its association with 
other variables, such as blood pressure. 
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